Chinese Medical E-ournals Database

Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition) ›› 2021, Vol. 17 ›› Issue (05): 566 -573. doi: 10.3877/cma.j.issn.1673-5250.2021.05.010

Original Article

Effects of storage time of whole blood samples on enzyme activity assay for diagnosis of mucopolysaccharidosis at low temperature

Tiantian He, Wencong Yao, Shanling Liu, He Wang, Xuemei Zhang()   

  • Received:2021-05-01 Revised:2021-09-11 Published:2021-10-01
  • Corresponding author: Xuemei Zhang
  • Supported by:
    Project of Science and Technology Department of Sichuan Province(2017SZ0111); New Bud Fund of West China Second University Hospital, Sichuan University(KX240)
Objective

To evaluate the impact of different storage time of enzymatic detection of whole blood samples on enzyme activity assays for the diagnosis of mucopolysaccharidosis (MPS) at low temperature (4 ℃), and provide experimental basis for controlling the storage time of MPS enzymatic samples before detection and the delivery time of samples.

Methods

From January 5 to 9, 2020, five healthy volunteers, two males and three females, aged 24 to 30 years, were enrolled. Six tubes of blood samples were collected from each volunteer and placed for testing at different time points (0, 24, 48, 72, 96, 120 h) after collection and named in order as samples 1, 2, 3, 4, 5. The remaining samples from 20 cases after peripheral blood cell chromosome examination at the Department of Medical Genetics & Prenatal Diagnosis Center of same hospital were also collected and mixed as the source of normal values of enzyme activity in this study. ① The impact of sample placement time on hemolysis was evaluated by visual observation and quantitative determination of free hemoglobin (f-Hb). ②Leukocytes were isolated and the activity of α-L-iduronidase (IDUA), α-N-acetylglucosaminidase (NAGLU), and β-glucuronidase (GUSB) were analyzed. The differences of enzyme activity at each time points mentioned above were compared. All subjects signed the clinical study informed consent forms, and the procedures followed in this study were in accordance with the ethical approval established by the Ethics Committee of West China Second University Hospital, Sichuan University, and approved by this committee (approval No. 20180094).

Results

① By visual observation, the longer time duration was, the deeper the color of the samples was. The color of plasmas began to turn red slightly at 72 h and became redder with the prolonged storage time. The results of quantitative analysis also showed that the level of f-Hb increased significantly at 72 h. With prolonged storage time, the degree of hemolysis became more deeper. ② There were no statistically significant differences in the levels of IDUA and NAGLU activity at 24, 48, 72, 96 and 120 h of sample 1-5 placement compared to 0 h, respectively (P>0.05). ③The difference between the GUSB activity levels of samples 1-5 at 24, 48, 72, and 96 h of placement compared with these at 0 h was also not statistically significant (P>0.05); however, the GUSB activity level was significantly lower at 120 h of placement than that at 0 h. The difference was statistically significant between them (t=4.601, P=0.002).

Conclusions

Considering various factors such as hemolysis and enzyme activity levels, it is recommended that peripheral blood samples for MPS enzymatic testing be delivered to the laboratory within 72 h (3 d) after collection, and that samples delivered between 72 and 120 h (3-5 d) depend on the quality of the sample and the type of lysosomal enzyme to be tested, with a high probability of test failure if delivered after 120 h (5 d).

表1 研究组血样1~5在4 ℃条件下放置0~120 h时的f-Hb水平检测结果(510 nm处相对吸光度值)
图2 研究组血样1~5在4 ℃条件下放置0、24、48、72、96、120 h时IDUA活性变化趋势折线图
表2 研究组血样1~5在4 ℃条件下放置0、24、48、72、96、120 h时IDUA[nmol/(h·mg)]检测结果及其与同批次对照组IDUA(正常值)比较的百分比(%)
表3 研究组血样1~5分别在4 ℃条件下放置0、24、48、72、96、120 h时NAGLU[nmol/(17 h·mg)]检测结果及其与同批次对照组NAGLU(正常值)比较的百分比(%)
图4 研究组血样1~5分别在4 ℃条件下放置0、24、48、72、96和120 h时GUSB活性变化趋势折线图
表4 研究组血样1~5在4 ℃放置0、24、48、72、96、120 h时的GUSB[nmol/(h·mg)]检测结果及其与同批次对照组GUSB(正常值)比较的百分比(%)
[1]
Khan SA, Tomatsu SC. Mucolipidoses overview: past, present, and future[J]. Int J Mol Sci, 2020, 21(18): 6812. DOI: 10.3390/ijms21186812.
[2]
Chen X, Qiu W, Ye J, et al. Demographic characteristics and distribution of lysosomal storage disorder subtypes in Eastern China[J]. J Hum Genet. 2016, 61(4): 345-349. DOI: 10.1038/jhg.2015.155.
[3]
Çelik B, Tomatsu SC, Tomatsu S, et al. Epidemiology of mucopolysaccharidoses update[J]. Diagnostics (Basel), 2021, 11(2): 273. DOI: 10.3390/diagnostics11020273.
[4]
Lin HY, Lin SP, Chuang CK, et al. Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004[J]. Am J Med Genet A, 2009, 149a(5): 960-964. DOI: 10.1002/ajmg.a.3278.
[5]
Lin HY, Lee CL, Chang CY, et al. Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985-2019)[J]. Orphanet J Rare Dis, 2020, 15(1): 314. DOI: 10.1186/s13023-020-01598-z.
[6]
Gaffke L, Pierzynowska K, Podlacha M, et al. Changes in cellular processes occurring in mucopolysaccharidoses as underestimated pathomechanisms of these diseases[J]. Cell Biol Int, 2021, 45(3): 498-506. DOI: 10.1002/cbin.11275.
[7]
Stapleton M, Arunkumar N, Kubaski F, et al. Clinical presentation and diagnosis of mucopolysaccharidoses[J]. Mol Genet Metab, 2018, 125(1-2): 4-17. DOI: 10.1016/j.ymgme.2018.01.003.
[8]
Mokhtariye A, Hagh-Nazari L, Varasteh AR, et al. Diagnostic methods for lysosomal storage disease[J]. Rep Biochem Mol Biol, 2019, 7(2): 119-128.
[9]
Daitx VV, Mezzalira J, Goldim MP, et al. Comparison between alpha-galactosidase A activity in blood samples collected on filter paper, leukocytes and plasma[J]. Clin Biochem, 2012, 45(15): 1233-1238. DOI: 10.1016/j.clinbiochem.2012.04.030.
[10]
王和,刘珊玲,刘之英,等. 孕早期绒毛高雪氏病产前诊断法[J]. 实用妇产科杂志2000, 16(1): 18-20. DOI: 10.3969/j.issn.1003-6946.2000.01.010.
[11]
Nybo M, Cadamuro J, Cornes MP, et al. Sample transportation-an overview[J]. Diagnosis (Berl), 2019, 6(1): 39-43. DOI: 10.1515/dx-2018-0051.
[12]
张雪梅,刘之英,陈新莲,等. 粘多糖贮积症Ⅱ型的酶学诊断、产前诊断及临床分析[J].第三军医大学学报2012, 34(2): 132-133. DOI: 10.1007/s11783-011-0280-z.
[13]
王和. 粘多糖贮积症Ⅰ型的酶学诊断与产前诊断[J/CD]. 中华妇幼临床医学杂志(电子版), 2005, 1(2): 131. DOI: 10.3969/j.issn.1673-5250.2005.02.027.
[14]
Marsh J, Fensom AH. 4-Methylumbelliferyl alpha-N-acetylglucosaminidase activity for diagnosis of Sanfilippo B disease[J]. Clin Genet. 1985, 27(3): 258-262. DOI: 10.1111/j.1399-0004.1985.tb00217.x.
[15]
张惠文,王瑜,叶军,等. 黏多糖贮积症47例的常见酶学分型[J].中华儿科杂志2009, 47(04): 276-280. DOI: 10.3760/cma.j.issn.0578-1310.2009.04.010.
[16]
Giavarina D, Lippi G. Blood venous sample collection: recommendations overview and a checklist to improve quality[J]. Clin Biochem, 2017, 50(10-11): 568-573. DOI: 10.1016/j.clinbiochem.2017.02.021.
[17]
Oemardien LF, Boer AM, Ruijter GJ, et al. Hemoglobin precipitation greatly improves 4-methylumbelliferone-based diagnostic assays for lysosomal storage diseases in dried blood spots[J]. Mol Genet Metab, 2011, 102(1): 44-48. DOI: 10.1016/j.ymgme.2010.09.008.
[18]
Archer IM, Harper PS, Wusteman FS. An improved assay for iduronate 2-sulphate sulphatase in serum and its use in the detection of carriers of the Hunter syndrome[J]. Clin Chim Acta. 1981, 112(1): 107-112. DOI: 10.1016/0009-8981(81)90274-6.
[19]
Yi F, Hong X, Kumar AB, et al. Detection of mucopolysaccharidosis Ⅲ-A (Sanfilippo Syndrome-A) in dried blood spots (DBS) by tandem mass spectrometry[J]. Mol Genet Metab, 2018, 125(1-2): 59-63. DOI: 10.1016/j.ymgme.2018.05.005.
[20]
Li D, Lin Y, Huang Y, et al. Early prenatal diagnosis of lysosomal storage disorders by enzymatic and molecular analysis[J]. Prenat Diagn, 2018, 38(10): 779-787. DOI: 10.1002/pd.5329.
[21]
Gelb MH, Lukacs Z, Ranieri E, et al. Newborn screening for lysosomal storage disorders: methodologies for measurement of enzymatic activities in dried blood spots[J]. Int J Neonatal Screen, 2019, 5(1): 1. DOI: 10.3390/ijns5010001.
[22]
Wenger DA, Luzi P. The lysosomal diseases testing laboratory: a review of the past 47 years[J]. JIMD Rep, 2020, 54(1): 61-67. DOI: 10.1002/jmd2.12117.
[23]
Baum H, Dodgson KS, Spencer B. The assay of arylsulphatases A and B in human urine[J]. Clin Chim Acta, 1959, 4(3): 453-455. DOI: 10.1016/0009-8981(59)90119-6.
[1] Xuemei Zhang, Qian Zhu, Hongmei Zhu, Xinlian Chen, Liangyu Xie, He Wang, Shanling Liu. Screening Effectiveness Analysis of Different Urine Screening Test for Mucopolysaccharidosis[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2014, 10(02): 161-164.
Viewed
Full text


Abstract